-
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Moderate Buy" from Brokerages
Source: Buzz FX / 22 Feb 2025 02:21:13 America/New_York
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Shares of Bio-Rad Laboratories, Inc.
Read more...